525 related articles for article (PubMed ID: 24013011)
1. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.
Wang Z; Liu G; Zheng H; Chen X
Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011
[TBL] [Abstract][Full Text] [Related]
2. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle-siRNA: A potential cancer therapy?
Young SW; Stenzel M; Yang JL
Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered nanoparticles for siRNA delivery.
Kozielski KL; Tzeng SY; Green JJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):449-68. PubMed ID: 23821336
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
[TBL] [Abstract][Full Text] [Related]
7. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.
Wu X; Wu M; Zhao JX
Nanomedicine; 2014 Feb; 10(2):297-312. PubMed ID: 24028896
[TBL] [Abstract][Full Text] [Related]
8. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
10. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
12. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
13. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
[TBL] [Abstract][Full Text] [Related]
14. Image-Guided Nanoparticle-Based siRNA Delivery for Cancer Therapy.
Kim YD; Park TE; Singh B; Maharjan S; Cho KS; Park KP; Choi YJ; Arote RB; Cho CS
Curr Pharm Des; 2015; 21(31):4637-56. PubMed ID: 26486148
[TBL] [Abstract][Full Text] [Related]
15. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.
Xu X; Wu J; Liu Y; Saw PE; Tao W; Yu M; Zope H; Si M; Victorious A; Rasmussen J; Ayyash D; Farokhzad OC; Shi J
ACS Nano; 2017 Mar; 11(3):2618-2627. PubMed ID: 28240870
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
Lee JM; Yoon TJ; Cho YS
Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
[TBL] [Abstract][Full Text] [Related]
19. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
